Characteristics and Outcomes of Patients Deferred for Transcatheter Aortic Valve Replacement Because of COVID-19

Richard Ro; Sahil Khera; Gilbert H L Tang; Parasuram Krishnamoorthy; Samin K Sharma; Annapoorna Kini; Stamatios Lerakis

doi:10.1001/jamanetworkopen.2020.19801

Characteristics and Outcomes of Patients Deferred for Transcatheter Aortic Valve Replacement Because of COVID-19

JAMA Netw Open. 2020 Sep 1;3(9):e2019801. doi: 10.1001/jamanetworkopen.2020.19801.

Authors

Richard Ro¹, Sahil Khera¹, Gilbert H L Tang², Parasuram Krishnamoorthy¹, Samin K Sharma¹, Annapoorna Kini¹, Stamatios Lerakis¹

Affiliations

¹ Division of Cardiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, New York.
² Department of Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, New York.

Abstract

This cohort study examines the characteristics and outcomes of patients for whom transcatheter aortic valve replacement (TAVR) was deferred because of the coronavirus disease 2019 (COVID-19) pandemic.

MeSH terms

Aged
Aged, 80 and over
Angina, Unstable / epidemiology
Aortic Valve Stenosis / mortality
Aortic Valve Stenosis / physiopathology*
Aortic Valve Stenosis / surgery
Betacoronavirus
COVID-19
Case-Control Studies
Coronary Artery Disease / epidemiology
Coronavirus Infections*
Disease Progression
Female
Heart Failure / epidemiology
Humans
Male
Pandemics*
Pneumonia, Viral*
SARS-CoV-2
Severity of Illness Index
Stroke / epidemiology
Stroke Volume
Syncope / epidemiology
Time-to-Treatment*
Transcatheter Aortic Valve Replacement*